Espraden sirve para la colitis
By clicking on Subscribe you will choose the content you want to receive in your email and you will be subscribed to our newsletter which you can cancel at any time; do not forget to check your Spam folder.
In studies published in the US National Library of Medicine National Institutes of Health, have proven its effectiveness in treatments against colitis, however according to a publication in the Revista de Gastroenterología de México, there is a risk of severe esophagitis due to this medication.
The treatment was immediately suspended and a month later, when a videogastroscopy was performed, the esophagus was found to be free of lesions, therefore, although it is a little known affectation and complication, it is important to know the contraindications.
Acute and recurrent diabetic gastroparesis. Prophylaxis of chemotherapy-induced nausea and vomiting. Short-term treatment of heartburn and delayed gastric emptying secondary to reflux esophagitis. Adjuvant of gastrointestinal radiography.
Concomitant use with alcohol may increase CNS depressant effects. Opioid-containing medications may antagonize the effects of metoclopramide on gastrointestinal motility. Metoclopramide may increase serum prolactin concentrations and interfere with the effects of bromocriptine. It accelerates the gastric emptying of levodopa, thus increasing the degree of absorption from the small intestine, and also accelerates the absorption of mexiletine.
Epilepsy, hemorrhage, mechanical obstruction or perforation at the gastrointestinal level, pheochromocytoma. The risk-benefit ratio should be evaluated in the presence of hepatic insufficiency, Parkinson’s disease and severe chronic renal insufficiency.
espraden is useful for colitis
Pathological Gastroesophageal Reflux Disease (GERD) is one of the most common problems in the general population; being the first cause of medical consultation and one of the simplest diseases to solve by laparoscopic surgery.
The burning, acidity and burning, which begins in the stomach, ascends through the chest (next to the heart) and can reach the neck. In severe cases, it can even cause pharyngitis, dysphonia (loss of voice) and coughing at night.
Sometimes, the food rises spontaneously to the mouth (regurgitation) causing halitosis and bad taste in the mouth. All these symptoms, which make a normal life impossible or difficult, are easy to diagnose by endoscopy.
The food that we ingest through the mouth, progresses through a tube called esophagus, located in the thorax. The thorax has a negative pressure with respect to the abdomen, while the abdomen exerts a positive pressure.
As a consequence of the difference in pressure, the viscera and gastric juices in the abdomen tend to pass into the thorax to balance pressure. For this reason, a Hernia of the Stomach (hiatal hernia) occurs, which consists of part of the stomach passing through the hiatus into the thorax. Hiatal or stomach hernia is the first cause of Gastroesophageal Reflux.
espraden en español
The recommended initial dose is 40 mg of Nexium mups twice daily. Thereafter, the dose should be adjusted for each patient and treatment should be continued as long as clinically indicated. Based on available clinical data, most patients can be controlled with doses of 80 to 160 mg of esomeprazole daily. If more than 80 mg daily is required, the dose should be divided and administered twice daily.
No dose adjustment is required in patients with impaired renal function. Due to limited experience in patients with severe renal impairment, such patients should be treated with caution. (See section 5.2).
No dose adjustment is required in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, a maximum dose of 20 mg of Nexium should not be exceeded. (See section 5.2).
20 mg once daily in patients without esophagitis. If symptom control has not been obtained after 4 weeks, treatment should be reconsidered. Once symptoms have resolved, further symptom control can be obtained using 20 mg once daily.